Multiple Myeloma Research Foundation
Last Modified: August 9, 2007
Conference Dates: October 5, 2007
Conference Location: Philadelphia, PA
Sponsoring Group: Multiple Myeloma Research Foundation
Conference Web Page URL: www.multiplemyeloma.org/symposia
Topics Covered: Clinical Controversies provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease, and supportive care.
Conference Objectives: Upon completion, participants should be able to: Identify the prognostic indicators and diagnostic approaches to multiple myeloma; Discuss the latest advances in stem cell transplantation, treatments for bone disease, and supportive care management; Describe the role and appropriate use of novel treatments for multiple myeloma throughout the disease progression.
Who Should Attend: Hematologists; Medical Oncologists; Oncology Nurses; Internests with recently diagnosed patients
Conference Agenda: Frontline Therapy; Transplant; Relapsed/Refractory Disease; Supportive Care; Clinical Trials; Panel Q&A and Evaluation
Registration Information: To register online visit www.multiplemyeloma.com/symposium; Email: email@example.com or call Sara Tyghter at 203.652.0219.
Conference Fees: Free
Continuing Education: Yes
Miscellany: Harvard Medical School designates this educational activity for a maximum of 2.75 AMA PRA Category 1 Credit(s).
Mar 9, 2010 - The presence and number of focal lesions detected by whole-body magnetic resonance imaging strongly predicts the conversion of asymptomatic multiple myeloma to symptomatic disease, according to a study published online Feb. 22 in the Journal of Clinical Oncology. In a related study in the same issue, researchers report that survival after treatment for multiple myeloma decreases with age.
May 3, 2012